Treatment of HIV-associated nephropathies

Nephron - Clinical Practice

Volumn 118, Issue 4, 2011, Pages

  Elewa, Usama ^a   Sandri, Ana Maria ^b   Rizza, Stacey A ^c   Fervenza, Fernando C ^d  

^a Cairo University   (Egypt)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c MAYO CLINIC   (United States)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

Human immunodeficiency virus; Nephropathy; Therapy

Indexed keywords

ABACAVIR; ACICLOVIR; AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DIDANOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; INDINAVIR; LAMIVUDINE; NELFINAVIR; PREDNISONE; SULFADIAZINE; TENOFOVIR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY TUBULE NECROSIS; ANTIHYPERTENSIVE THERAPY; CREATININE BLOOD LEVEL; CRYSTAL NEPHROPATHY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBULE DISORDER; NEPHROTIC SYNDROME; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SURVIVAL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AIDS-ASSOCIATED NEPHROPATHY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV-1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79551555011     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000323666     Document Type: Review

References (59)

1. UNAIDS: Report on the Global HIV/AIDS Epidemic 2008: Executive Summary. Mexico City, UNAIDS, 2008.
2. Sepkowitz KA: One disease, two epidemics -AIDS at 25. N Engl J Med 2006; 354: 2411-2414. (Pubitemid 43855043)
3. Kimmel PL, Barisoni L, Kopp JB: Pathogenesis and treatment of HIV-associated renal diseases: Lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med 2003; 139: 214-226. (Pubitemid 38124604)
4. Wyatt CM, Klotman PE: HIV-1 and HIV-associated nephropathy 25 years later. Clin J Am Soc Nephrol 2007; 2(suppl 1):S20-S24.
5. Han TM, Naicker S, Ramdial PK, Assounga AG: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69: 2243-2250. (Pubitemid 43882112)
6. Szczech LA, Gupta SK, Habash R, Guasch A, et al: The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004; 66: 1145-1152. (Pubitemid 39121021)
7. Nochy D, Glotz D, Dosquet P, Pruna A, et al: Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 1993; 8: 11-19. (Pubitemid 23050590)
8. Connolly JO, Weston CE, Hendry BM: HIVassociated renal disease in London hospitals. QJM 1995; 88: 627-634.
9. Winston JA, Klotman ME, Klotman PE: HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 1999; 55: 1036-1040. (Pubitemid 29100716)
10. Berliner AR, Fine DM, Lucas GM, Rahman MH, et al: Observations on a cohort of HIVinfected patients undergoing native renal biopsy. Am J Nephrol 2008; 28: 478-486. (Pubitemid 351501614)
11. Cohen SD, Kimmel PL: Immune complex renal disease and human immunodeficiency virus infection. Semin Nephrol 2008; 28: 535-544.
12. Go AS, Chertow GM, Fan D, McCulloch CE, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
13. Szczech LA, Hoover DR, Feldman JG, Cohen MH, et al: Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39: 1199-1206. (Pubitemid 40169320)
14. Kalayjian RC: The treatment of HIV-associated nephropathy. Adv Chronic Kidney Dis 2010; 17: 59-71.
15. Nebuloni M, Tosoni A, Barbiano di Belgiojoso G, Rastaldi MP: HIV infection and chronic kidney disease. Eur Nephrol 2010; 4: 19-23.
16. Haas M, Kaul S, Eustace JA: HIV-associated immune complex glomerulonephritis with 'lupus-like' features: A clinicopathologic study of 14 cases. Kidney Int 2005; 67: 1381-1390. (Pubitemid 40463114)
17. Fine DM, Perazella MA, Lucas GM, Atta MG: Kidney biopsy in HIV: Beyond HIV-associated nephropathy. Am J Kidney Dis 2008; 51: 504-514. (Pubitemid 351273482)
18. Cohen SD, Kimmel PL: Renal biopsy is necessary for the diagnosis of HIV-associated renal diseases. Nat Clin Pract Nephrol 2009; 5: 22-23.
19. Gerntholtz TE, Goetsch SJ, Katz I: HIV-related nephropathy: A South African perspective. Kidney Int 2006; 69: 1885-1891. (Pubitemid 43739220)
20. Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, et al: Chronic kidney disease in HIV infection: An urban epidemic. AIDS 2007; 21: 2101-2103. (Pubitemid 47462160)
21. Wyatt CM, Morgello S, Katz-Malamed R, Wei C, et al: The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75: 428-434.
22. Cornely OA, Hauschild S, Weise C, Csernok E, et al: Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection. Infection 1999; 27: 92-96. (Pubitemid 29142161)
23. Klaassen RJ, Goldschmeding R, Dolman KM, Vlekke AB, et al: Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 1992; 87: 24-30.
24. Savige JA, Chang L, Horn S, Crowe SM: Antinuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994; 18: 205-211. (Pubitemid 24344809)
25. Davenport A, Grant PJ: False positive autoantibodies in HIV infection. Nephron 1991; 59: 515-516.
26. Calabrese LH: Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clin Exp Rheumatol 2004; 22:S87-S93.
27. Monteiro EJ, Caron D, Balda CA, Franco M, et al: Anti-glomerular basement membrane glomerulonephritis in an HIV-positive patient: Case report. Braz J Infect Dis 2006; 10: 55-58. (Pubitemid 43881095)
28. Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, et al: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22: 481-487. (Pubitemid 351317289)
29. Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, et al: Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18: 2171-2178. (Pubitemid 39463682)
30. Babut-Gay ML, Echard M, Kleinknecht D, Meyrier A: Zidovudine and nephropathy with human immunodeficiency virus infection. Ann Intern Med 1989; 111: 856-857. (Pubitemid 19283929)
31. Ifudu O, Rao TK, Tan CC, Fleischman H, et al: Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 1995; 15: 217-221.
32. Kirchner JT: Resolution of renal failure after initiation of HAART: Three cases and a discussion of the literature. AIDS Read 2002; 12: 103-105, 110-112.
33. Szczech LA, Edwards LJ, Sanders LL, van der Horst C, et al: Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 2002; 57: 336-341. (Pubitemid 34477470)
34. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, et al: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283-2296. (Pubitemid 44837777)
35. Scheurer D: Rapid reversal of renal failure after initiation of HAART: A case report. AIDS Read 2004; 14: 443-447. (Pubitemid 39050584)
36. Scialla JJ, Atta MG, Fine DM: Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy. AIDS 2007; 21: 263-264. (Pubitemid 46036946)
37. Atta MG, Gallant JE, Rahman MH, Nagajothi N, et al: Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 2809-2813. (Pubitemid 44542235)
38. Longenecker CT, Scherzer R, Bacchetti P, Lewis CE, et al: HIV viremia and changes in kidney function. AIDS 2009; 23: 1089-1096.
39. Lucas GM, Eustace JA, Sozio S, Mentari EK, et al: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. Aids 2004; 18: 541-546. (Pubitemid 38365883)
40. Gupta SK, Smurzynski M, Franceschini N, Bosch RJ, et al: The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era. Antivir Ther 2009; 14: 543-549.
41. Gupta SK, Parker RA, Robbins GK, Dube MP: The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: Results from a randomized trial. Nephrol Dial Transplant 2005; 20: 2237-2242. (Pubitemid 41510103)
42. Jafar TH, Stark PC, Schmid CH, Landa M, et al: Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann Intern Med 2003; 139: 244-252.
43. Kimmel PL, Mishkin GJ, Umana WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 1996; 28: 202-208. (Pubitemid 26286655)
44. Burns GC, Paul SK, Toth IR, Sivak SL: Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 1997; 8: 1140-1146. (Pubitemid 27427222)
45. Wei A, Burns GC, Williams BA, Mohammed NB, et al: Long-term renal survival in HIVassociated nephropathy with angiotensinconverting enzyme inhibition. Kidney Int 2003; 64: 1462-1471. (Pubitemid 37153814)
46. Laradi A, Mallet A, Beaufils H, Allouache M, et al: HIV-associated nephropathy: Outcome and prognosis factors. Groupe d'Etudes Né phrologiques d'Ile de France. J Am Soc Nephrol 1998; 9: 2327-2335.
47. Eustace JA, Nuermberger E, Choi M, Scheel PJ Jr., et al: Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int 2000; 58: 1253-1260.
48. Smith MC, Austen JL, Carey JT, Emancipator SN, et al: Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 1996; 101: 41-48. (Pubitemid 26285939)
49. Glesby MJ, Hoover DR, Vaamonde CM: Osteonecrosis in patients infected with human immunodeficiency virus: A case-control study. J Infect Dis 2001; 184: 519-523. (Pubitemid 32718519)
50. Miller KD, Masur H, Jones EC, Joe GO, et al: High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002; 137: 17-25.
51. Navarrete JE, Pastan SO: Effect of highly active antiretroviral treatment and prednisone in biopsy-proven HIV-associated nephropathy (abstract). J Am Soc Nephrol 2000; 11: 93A.
52. Ingulli E, Tejani A, Fikrig S, Nicastri A, et al: Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr 1991; 119: 710-716.
53. Yahaya I, Uthman AO, Uthman MM: Interventions for HIV-associated nephropathy. Cochrane Database Syst Rev 2009:CD007183.
54. Bansi L, Hughes A, Bhagani S, Mackie NE, et al: Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009; 23: 2517-2521.
55. Fine DM, Perazella MA, Lucas GM, Atta MG: Renal disease in patients with HIV infection: Epidemiology, pathogenesis and management. Drugs 2008; 68: 963-980. (Pubitemid 351652924)
56. Hammer SM, Eron JJ Jr., Reiss P, Schooley RT, et al: Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300: 555-570.
57. Roling J, Schmid H, Fischereder M, Draenert R, et al: HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis 2006; 42: 1488-1495.
58. Cohen SD, Chawla LS, Kimmel PL: Acute kidney injury in patients with human immunodeficiency virus infection. Curr Opin Crit Care 2008; 14: 647-653.
59. Reid A, Stohr W, Walker AS, Williams IG, et al: Severe renal dysfunction and risk factors associated with renal impairment in HIVinfected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008; 46: 1271-1281. (Pubitemid 351589914)